$0.54
5.69% today
Nasdaq, Apr 04, 08:45 pm CET
ISIN
US23725P1003
Symbol
DRIO

DarioHealth Corp. Stock price

$0.58
-0.07 10.21% 1M
-0.46 44.59% 6M
-0.21 26.69% YTD
-0.85 59.70% 1Y
-5.52 90.55% 3Y
-4.54 88.74% 5Y
-105.62 99.46% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.05 8.48%
ISIN
US23725P1003
Symbol
DRIO
Sector

Key metrics

Market capitalization $23.96m
Enterprise Value $25.51m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.94
P/S ratio (TTM) P/S ratio 0.89
P/B ratio (TTM) P/B ratio 0.31
Revenue growth (TTM) Revenue growth 32.86%
Revenue (TTM) Revenue $27.04m
EBIT (operating result TTM) EBIT $-57.02m
Free Cash Flow (TTM) Free Cash Flow $-38.70m
Cash position $28.64m
EPS (TTM) EPS $-0.79
P/E forward negative
P/S forward 0.74
EV/Sales forward 0.79
Short interest 6.73%
Show more

Is DarioHealth Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

DarioHealth Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a DarioHealth Corp. forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a DarioHealth Corp. forecast:

Buy
67%
Hold
33%

Financial data from DarioHealth Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
27 27
33% 33%
100%
- Direct Costs 14 14
4% 4%
51%
13 13
122% 122%
49%
- Selling and Administrative Expenses 38 38
3% 3%
139%
- Research and Development Expense 24 24
19% 19%
89%
-49 -49
5% 5%
-179%
- Depreciation and Amortization 8.48 8.48
62% 62%
31%
EBIT (Operating Income) EBIT -57 -57
2% 2%
-211%
Net Profit -30 -30
45% 45%
-111%

In millions USD.

Don't miss a Thing! We will send you all news about DarioHealth Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DarioHealth Corp. Stock News

Neutral
Business Wire
11 days ago
NEW YORK--(BUSINESS WIRE)--Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO)* emerges as a potential hidden gem in digital health as competitor Hinge Health prepares to go public at a multi-billion-dollar valuation, highlighting a dramatic valuation gap that savvy investors are beginning to notice. With Hinge Health filing for a potential April IPO at a valuation that according to re...
Neutral
PRNewsWire
18 days ago
In the news release, DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base, issued 06-Feb-2025 by DarioHealth Corp. over PR Newswire, we are advised by the company to make multiple changes to the press release. The complete, corrected release follows: DarioHealth Announces New Agreement with a Large Regional Health Plan DarioHealth expands its payer netwo...
Neutral
Seeking Alpha
25 days ago
DarioHealth Corp. (NASDAQ:DRIO ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome t...
More DarioHealth Corp. News

Company Profile

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

Head office United States
CEO Erez Raphael
Employees 202
Founded 2011
Website www.dariohealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today